00 / 00
Assistant Professor, Department of Hematology/Oncology
Collaborating Member, Cancer Epigenetics
Chemotherapy, targeted chemotherapy, immunotherapy, hormone therapy, clinical trials for genitourinary malignancies
I am a medical oncologist specializing in genitourinary cancers. Treating patients with cancer is a privilege for me as in the process of diagnosing and treating the illness I get to become the patient’s friend, resource and advocate. In the most difficult times of their life, each cancer patient and their family deserves the best possible care. I strive to provide excellent care by being a good listener, maintaining good communication with patients and my team, staying abreast with the rapidly evolving field of oncology and by providing individualized care to each patient.
I came to Fox Chase for my fellowship and stayed here because I loved the team and realized that at Fox Chase, each patient has the benefit of an interdisciplinary team working together to ensure the highest quality care. This team approach is crucial in determining and implementing the best treatment plan.
In my clinical practice I focus on the care of patients with kidney, prostate bladder, penile, adrenal and testicular cancer and I am proud to be part of a large multidisciplinary team of distinguished clinicians and researchers at Fox Chase. Over the last decade, the number of treatment options for patients with advanced cancers has greatly expanded and at Fox Chase we can offer both the latest standard-of-care as well as new experimental approaches. My particular research interest is in developing biomarkers that can help understand the behavior of kidney cancers as well as clinical trial development for genitourinary cancers.
Nicolas E, Demidova E… Ghatalia P .. Arora, S. Interaction of germline variants in a family with a history of early-onset clear cell renal cell carcinoma. Molecular Genetics & Genomic Medicine. 2019 Jan. Cited in Pubmed: PMID 30680959
Ghatalia P, Smith C, Winer A, Gou J, Kiedrowski L, Slifker M, Saltzberg P, Bubes N, Anari F, Kasireddy V, Varshavsky A, Liu Y, Ross EA, El-Deiry W. Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Frontiers in Oncology. 2019 Jan. Cited in Pubmed: PMID 30705875
Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma. Clin Adv Hematol Oncol. 2018 16(10): 677-86. Cited in Pubmed; PMID 30543598
Nam HY, Chandrashekhar DS .. Ghatalia P .. Sudarshan S. Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis. Mol Cancer Res. 2018 Aug. Cited in Pubmed; PMID 30131446
Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM. Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies. Mol Cancer Ther. 2018 17(7): 1355-64. Cited in Pubmed; PMID 29967214
Morrison C, Pabla S .. Ghatalia P… Ernstoff MS. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden. J Immunotherapy. 2018 6(1):32. Cited in Pubmed; PMID: 29743104
Agarwal N, Pal SK .. Ghatalia P…Grivas P. Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA. Cancer. 2018 124(10): 2115-24. Cited in Pubmed; PMID: 29517810
Ghatalia P, Rathmell K. ClearCode 34: A validated prognostic signature in clear cell renal cell carcinoma (ccRCC). Kidney Cancer 2018 2(1): 23-29. Cited in Pubmed; PMID 30320241
Ghatalia P, Koenigsberg R, Pisarcik D, Handorf E, Geynisman D, Zibelman M. The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov Website. Kidney Cancer 2017 1(2): 151-159. Cited in Pubmed; PMID: 30334017
Ghatalia P, Nagarathinam R, Cooper H, Geynisman DM, El-Deiry WS. Mismatch repair deficient metastatic colon cancer and urothelial cancer: a case report of sequential immune checkpoint therapy. Cancer biology and Therapy 2017 July. [Epub ahead of print]
Ghosh AP, Willey CD, Anderson, JC, Welaya K, Mehta, A, Ghatalia P. Kinomic Profiling Identifies Focal Adhesion Kinase 1 as a Therapeutic Target in Advanced Clear Cell Renal Cell Carcinoma. OncoTarget 2017 Apr; 8(17): 29220-32. Cited in Pubmed; PMID: 28418903
Ghatalia P, Zibelman M, Geynisman DM, Plimack ER Checkpoint inhibitors for the Treatment of Renal Cell Carcinoma. Current Treatment Options in Oncology 2017 Jan; 18(1): 7. Cited in Pubmed; PMID: 28210995
Jung K, Ghatalia P, Litwin S, Horwitz EM, Uzzo RG, Greenberg RE, Viterbo R, Geynisman DM, Kutikov A, Plimack ER, Smaldone MC, Wong YN, Bilusic M. Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clinical Genitourinary Cancer. 2016 Sep. [Epub ahead of print]. Cited in Pubmed; PMID 27991416
Ghatalia P, Yang E, Lasseigne BN, Ramaker RC, Cooper SJ, Chen D, Sudarshan S, Wei S, Guru A, Zhao A, Cooper T, Naik G, Myers RM, Sonpavde G. Kinase gene expression profiling of metastatic clear cell renal cell carcinoma tissue identifies potential new drivers and therapeutic targets. PLOS One 2016 Aug; 11 (8). Cited in Pubmed; PMID 27574806
Zibelman M, Ghatalia P, Geynisman D, Plimack E. Checkpoint Inhibitors for Renal Cell Carcinoma: Current Landscape and Future Directions. Immunotherapy. 2016 June; 8: 785-98. Cited in Pubmed; PMID 27349978
Ghatalia P, Morgan C, Sonpavde G. Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials. Critical Reviews in Oncology/ Hematology. 2016 Feb; 98: 122-36. Cited in Pubmed; PMID 26597016
Anderson JC, Willey CD, Mehta A, Welaya K, Chen D, Duarte CW, Ghatalia P, Arafat W, Madan A, Sudarshan S, Naik G, Grizzle WE, Choueiri TK, Sonpavde G. High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes. PLoS One. 2015 Sep 25;10 (9). Cited in Pubmed; PMID 26406598
Ghatalia P, Je Y, Nguyen PL, Trinh QD, Choueiri TK, Sonpavde G. Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials. Critical Reviews in Oncology/ Hematology. 2015 Aug; 95(2):251-63. Cited in Pubmed; PMID 25900071
Ghatalia P, Je Y, Kaymakcalan MD, Sonpavde G, Choueiri TK. QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors. British Journal of Cancer. 2015 Jan; 112(2): 296-305. Cited in Pubmed; PMID 25349964
Ghatalia P, Morgan C, Choueiri TK, Sonpavde G. Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Critical Reviews in Oncology/ Hematology. 2015 May; 94(2): 228-37 PMID 25577572
Ghatalia P, Morgan C, Choueiri TK, Rocha P, Naik G, Sonpavde G. Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Critical Reviews in Oncology/ Hematology. 2015 Apr; 94(1):136-45 PMID 25541349
Ghatalia P, Je Y, Mouallem NE, Nguyen PL, Trinh Q, Sonpavde G, Choueiri TK. Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials. Critical Reviews in Oncology/Hematology. 2015 Mar; 93(3):257-76. Cited in Pubmed; PMID 25523486
Ghatalia P, Vick A, Vattoth S, Roberson G, Pappas P. Reversible blindness in cryptococcal meningitis with normal intracranial pressure. Clinical Infectious Diseases. 2014 July; 59(2): 310-3. Cited in Pubmed; PMID 24704725
Ghatalia P, Porter J, Wroblewski D, Carlson JA. Primary cutaneous marginal zone lymphoma associated with juxta-articular fibrotic nodules in a teenager. Journal of Cutaneous Pathology. 2013 May; 40(5): 477-84. Cited in Pubmed; PMID 23578183 Collapse
The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.